Skip to main content
Blood Advances logoLink to Blood Advances
. 2017 Jul 31;1(18):1368. doi: 10.1182/bloodadvances.2017010421

Reina-Castillón J, Pujol R, López-Sánchez M, et al. Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia. Blood Adv. 2017;1(5):319-329.

PMCID: PMC5727859  PMID: 29297518

In the “Inclusion in Kaplan-Meier analysis” column of Table S3 of the supplemental table file, the entries for the following 12 cells were incorrect: H25, H26, H35, H37, H44, H47, H51, H54, H57, H61, H64, and H67. The error has been corrected in the online data supplement.


Articles from Blood Advances are provided here courtesy of The American Society of Hematology

RESOURCES